版本:
中国

BRIEF-Rxi Pharmaceuticals reports Q4 loss per share $0.60

March 30 Rxi Pharmaceuticals Corp

* Rxi Pharmaceuticals reports fourth quarter and year end 2016 financial results and recent corporate highlights

* Believes that its existing cash should be sufficient to fund operations for at least next twelve months

* Qtrly loss per share $0.60

* Rxi Pharmaceuticals Corp - research and development expense for quarter was $1.3 million compared with $1.7 million Source text for Eikon: Further company coverage:

我们的标准: 汤森路透“信任原则

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐